Aragonese thirty attend an information session on Diabesity.

– according to the latest data published by the National Institute of statistics (INE), in Aragón around 573.300 people are overweight or obese and around 56.871 with diabetes

– the meeting held under the auspices of the Associationon diabetic Zaragoza, which has been very active in the dissemination of this meeting

Zaragoza, February 2013.- around 30 Aragonese came last Thursday 24 5th Infoday on Diabesity, for type 2 diabetic patients, which took place in the official College of physicians of Zaragoza. The initiative is part of a series of informational meetings whose objective is to offer solutions and new tools for the treatment of the diabesity (obesity + type 2 diabetes). Diabetics and with the collaboration of PronoKal ® Zaragoza Association-sponsored Group, a firm specializing in the treatment of weight loss protein-based diet, this fifth day became the first of 2013, giving continuity to the initiative that last year he visited cities such as Santiago de Compostela and Barcelona.

Dr. Vicente Blay, specialist in Endocrinology, was commissioned to provide for more than one hour talk Diabesity. New treatment of diabetic patient type 2 overweight: method Diaprokal ® ”, which was greatly valued by attendees. At the end of the activity, one of the issues most valued by attendees was the capacity offered by the method of enjoying results from the first day. At this point, the doctor introduced the concept of the importance of not only having good results at the beginning, but that these can be maintained in the long term, thanks to the modification of lifestyle by the patient.

This Conference aims to inform the patient diabesico of the importance of detecting and treating much before their obesity and diabetes. To achieve a more complete approach, it is recommended that treatment focuses not only on the approach of one of the two diseases, but in them in a way joint. ” said Dr. Ignacio Sajoux, Medical Adviser of PronoKal ®.

From the hands of a local expert and like that in the rest of former days, its development is divided into three sections. First, is a review of the main figures of prevalence of obesity and diabetes in Spain. Here, the method is DiaproKal ®, a new specific treatment based on diet protein to patients with excess weight and DM2 or pre-diabetes and, finally, presents the results of the study DiaproKal ®, a clinical trial that evaluated the efficacy and safety of dietary protein vs. a diet low calorie in this type of patients.

The method DiaproKal ®

during the meeting, Dr. Blay explained that the method DiaproKal ® has a protocol developed specifically for the treatment of the obese patient or with overweight and diabetes type 2 or pre-diabetes. This treatment intends to take the patient to a State of metabolic normalization where their weight, their waist circumference and its glycemic control figures are in normal parameters.

This new treatment was born in 2012, on the occasion of the good results obtained in the study DiaproKal ®, whose figures are established as one of the main issues of interest to attendees.

Thus, Dr. Blay revealed that after 4 months of follow-up, the final results of the study are very relevant and provide an excellent alternative for the treatment of these patients, since they show that the protein diet (DiaproKal ®) is as safe as the low calorie diet and more effective in the improvement of control Glycemic and the weight loss in type 2 diabetic patients with obesity. In fact, the main results so far show that 80% of the patients treated with diet protein present venous blood sugar normalized values (< 126 mg/dl), while in the group with low calorie diet only 61.1% of patients reach them. This data is a breakthrough in the approach to this type of patients because treatment is essentially focused on the modification of lifestyle, getting control and improvement, in turn, of their Glycemic metabolism.

also, the decrease of the perimeter of waist (PC) achieved with dietary protein, it is more than double that with hypocaloric diet group, which emphasizes the interest of this data as a new therapeutic and key element in the improvement of these patients, given the relationship between intra-abdominal fat and insulin resistance. In particular, the PC made by the patients in the study treated with diet protein meant an average reduction of 12,03 cm, versus those that are low calorie diet, which only achieved an average reduction of 5.54 cm.

The Diabesity in Aragon

Figures from the latest European health survey conducted by the National Statistical Institute in 2009, 15% of Aragonese suffering obesity and 38% overweight, which means that a total of 573.300 Aragonese suffer from any of these two pathologies. Going into detail, being overweight is more frequent in men than in women, affecting a 48.7% of the first compared to 28% of the latter. Finally, according to the same study, more than 56,000 Aragonese suffer from diabetes.

About DiaproKal ®

The method DiaproKal ® arrives to Spain at the hands of PronoKal ® Group, a firm based in Barcelona with offices in Barcelona, Madrid and Valencia, with a team consisting of more than 180 people. The method DiaproKal ® is a multidisciplinary treatment of weight loss and maintenance, for patients with diabetes type 2 or pre-diabetes, diet-based protein and under medical control.

DiaproKal ® has a multidisciplinary team that allows to approach the patient from all possible areas and a menu of flavors composed more than 30 products with different textures and flavors to make more bearable the active stages and metabolic stabilization. To this day, are already more than 500 physicians specifically trained for the prescription of this method and 20, dietitians-the nutritionists specializing in diabetes, giving support and advice to the patient during the whole process of weight loss and its lifestyle modification. In terms of physical activity, which is inescapably part of the method, DiaproKal ® has also a broad team of fixed collaborators specialized in the control and monitoring of physical activity in diabetic patients, as well as with experts in coaching, that accompany the patient throughout the process.

Both medical prescribers of DiaproKal ®, and the team of nutritionists-dietitians and physical activity and coaching consultants follow a program of updates on the method, the prescription of specific physical activity for diabetics, the management and monitoring of diabetic patients, in order to update and increase their knowledge about both pathologies. The safety and efficacy of the method has been analyzed through the clinical trial DiaproKal ®, whose results are being very positive and presented in the main scientific forums in the country.

To consult the medical prescriber’s method DiaproKal ® nearest, call 901-100-272.